Overview


Hospital pharmaceuticals are those purchased by hospitals for the treatment of inpatients or outpatients. Hospital pharmaceutical drugs include drugs used in infections, the gastrointestinal tract, metabolism, cardiology, urology, neurology, sensory organs, musculoskeletal system, respiratory system, dermatology, hematology, and others. Hospital pharmacies are responsible for procuring, storing, and selling medications. Pharmaceuticals for hospitals are medicines purchased for hospitals and healthcare centers in order to be administered to patients during hospitalized treatment periods. Legislation does not regulate the procurement of pharmaceuticals for inpatients. When bulk purchases are made, the price of hospital pharmaceuticals is negotiated between the hospital pharmacy and pharmaceutical company. The purchasing price of hospital formularies can be negotiated by hospital pharmacies with industry officials in accordance with hospital needs and competition between suppliers. Pharmac, a government agency, makes decisions about which medicines should be publicly funded in order to help patients get medicines at subsidized prices and decide what the District Health Board (DHB) should spend on medical care. With their expanded horizons in vaccines, haemophilia treatments, cancer treatments, and hospital medicines, pharmacists make decisions on medicines funded in DHB hospitals and negotiate hospital medicine budgets. Pharmac publishes their pharmaceutical schedule annually with lists of subsidised medicines and drugs. In addition to formulations, doses, subsidy price of medicines, and prescribing guidelines, the pharmaceutical schedule list is accessible to health professionals and pharmacists. In addition, cardiovascular diseases will also fuel global hospital pharmaceuticals demand. Increasing government initiatives, increasing disease awareness, and therapeutic interventions aimed at reducing cardiovascular ailments are likely to boost hospital pharmaceutical demand. In the near future, the global hospital pharmaceuticals market is likely to benefit from the rapid occurrence of chronic diseases such as diabetes, cancer, and cardiovascular ailments. Additionally, increasing healthcare expenses throughout developing countries may further drive the demand for hospital pharmaceuticals in the near future. As the number of parasitic infections increases, hospital demand for anti-parasitic drugs is expected to increase. Additionally, the rising number of cancer patients will continue to drive the market forward in the years to come.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Hospital Pharmacies Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Hospital Pharmacies Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Bayer AG
  • Novartis AG
  • Pfizer Inc
  • AstaZeneca Plc
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • F.Hoffmann-La Roche Ltd
  • Sanofi Sa
  • Merck & Co., Inc
  • Eli Lilly and Company

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Application

  • Cardiology
  • Oncology
  • Nephrology
  • Urology
  • Neurology
  • Pain and Infection

By Therapeutic Area

  • Hormone Replacement
  • Pain Management
  • Dermatology Applications
  • Specialty Drugs
  • Nutritional Supplements

By Product

  • Oral
  • Topical
  • Parental
  • Nasal
  • Others

By End User

  • Intensive Care Units
  • Surgery Wards
  • Burn Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa
  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Hospital Pharmacies Market By Application, By Therapeutic Area, By Product, By End User and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Hospital Pharmacies Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Hospital Pharmacies Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Hospital Pharmacies Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Hospital Pharmacies Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Cardiology
        2. Oncology
        3. Nephrology
        4. Urology
        5. Neurology
        6. Pain and Infection

  • 8.   Hospital Pharmacies Market, By Therapeutic Area Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hormone Replacement
        2. Pain Management
        3. Dermatology Applications
        4. Specialty Drugs
        5. Nutritional Supplements

  • 9.   Hospital Pharmacies Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Topical
        3. Parental
        4. Nasal
        5. Others

  • 10.   Hospital Pharmacies Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Intensive Care Units
        2. Surgery Wards
        3. Burn Centers
        4. Others

  • 11.   North America Hospital Pharmacies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Hospital Pharmacies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Hospital Pharmacies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Hospital Pharmacies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Hospital Pharmacies Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Bayer AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Novartis AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Pfizer Inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. AstaZeneca Plc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. GlaxoSmithKline Plc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Johnson & Johnson
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. F.Hoffmann-La Roche Ltd
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Sanofi Sa
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Merck & Co., Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Eli Lilly and Company
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients